FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

36936711000001101: Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
113265601000001112 Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113265701000001119 Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Is a Paclitaxel 300mg/50ml solution for infusion vials true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has active ingredient Paclitaxel true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has specific active ingredient Paclitaxel true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has excipient Polyoxyl castor oil false Inferred relationship Existential restriction modifier
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) 1 vial Has AMP True Paclitaxel 300mg/50ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start